News
05-08-2020, 08:12 AM
The anti-cancer medicine venetoclax could improve the current therapy for estrogen receptor-positive breast cancer - the most common form of breast cancer in Australia - according to preclinical studies led by Walter and Eliza Hall Institute researchers.
More... (https://www.news-medical.net/news/20200508/Novel-anti-cancer-medicine-could-improve-current-therapy-for-ER2b-breast-cancer.aspx)
More... (https://www.news-medical.net/news/20200508/Novel-anti-cancer-medicine-could-improve-current-therapy-for-ER2b-breast-cancer.aspx)